Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from allium
Reexamination Certificate
2007-04-10
2007-04-10
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from allium
C514S052000, C514S161000, C514S249000, C514S345000, C514S565000
Reexamination Certificate
active
11323091
ABSTRACT:
The invention relates generally to an aspirin formulation which may comprise additional vitamins, minerals, herbs and supplements and methods for using the same for maintaining cardiovascular health. The aspirin formulation may comprise supplements such as vitamin B6, vitamin B12, folic acid, arginine and garlic. The invention also encompasses methods for maintaining healthy blood pressure and cholesterol levels with the aspirin formulation described herein.
REFERENCES:
patent: 5770215 (1998-06-01), Moshyedi
patent: 5948443 (1999-09-01), Riley et al.
patent: 6129918 (2000-10-01), Amagase
patent: 6369059 (2002-04-01), Daugan
patent: 6914073 (2005-07-01), Boulos et al.
patent: 6953593 (2005-10-01), Kuhrts
patent: 2002/0172721 (2002-11-01), Boulos et al.
patent: 2003/0054978 (2003-03-01), Babish
patent: 2003/0068365 (2003-04-01), Suvanprakorn et al.
patent: 2004/0157932 (2004-08-01), Saebo
patent: 2004/0224012 (2004-11-01), Suvanprakorn et al.
patent: 2005/0147675 (2005-07-01), Petrus
patent: 2005/0233944 (2005-10-01), Babish
patent: 2005/0260262 (2005-11-01), Dansereau et al.
patent: 2006/0153823 (2006-07-01), Giordano et al.
patent: WO 98/41195 (1998-09-01), None
patent: WO 03/020260 (2003-03-01), None
patent: WO 03/030818 (2003-04-01), None
Handbook of Pharmaceutical Excipients, published by American Pharmaceutical Association (1986), pp. 138-140, 296, 297, 349 and 350.
“Wakunaga Products”, retrieved from “http://www.kyolic.com/productpage.htm” on Nov. 18, 2006.
“Kyolic Aged Garlic Extract”, retrieved from “http://www.healingwithnutrition.com/products/kyolicgarlic.html” on Nov. 18, 2006.
Gorelick & Weisman, “Risk of Hemorrhagic Stroke With Aspirin Use”, Stroke. Aug. 2005;36(8):1801-7. Epub Jul. 14, 2005.
Mahe et al., “Aspirin for the Prevention of Cardiovascular Events in the Elderly”, Drugs Aging. 2003;20(13):999-1010.
Newton et al., “Review article: the ageing bowel and intolerance to aspirin”, Aliment Pharmacol Ther. Jan. 1, 2004;19(1):39-45.
Osiecki, “The Role of Chronic Inflammation in Cardiovascular Disease and its Regulation by Nutrients”, Altern Med Rev. Mar. 2004;9(1):32-53.
Sibilia et al., “Les complications digestives et hemorragiques de l'aspirine a faible dose” Presse Med. Nov. 22, 2003;32(37 Pt 2):S17-28.
Alan James Group, LLC.
Frommer & Lawrence & Haug LLP
Henley III Raymond J.
Wakunaga of America Co., Ltd.
LandOfFree
Aspirin formulation for cardiovascular health does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aspirin formulation for cardiovascular health, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aspirin formulation for cardiovascular health will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3790203